Skip to main content
Clinical Trials/CTRI/2024/04/065171
CTRI/2024/04/065171
Not Yet Recruiting
N/A

To study the potential of a predictive Artificial Intelligence tool to foster early identification of symptoms and criticality in breast and cervical cancers in Indian patients. - NI

AIIMS New Delhi0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified
Sponsor
AIIMS New Delhi
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Sponsor
AIIMS New Delhi

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient with diagnoses of carcinoma breast and carcinoma cervix
  • 2\.Willing to give consent for enrollment in the study.
  • 4\.Able to understand Hindi or English
  • 5\.Able to communicate properly

Exclusion Criteria

  • 1\. Unable to understand or answer a clinician\-administered ESAS symptom questionnaire

Outcomes

Primary Outcomes

Not specified

Similar Trials